CHICAGO, Oct 25 (Reuters) - PDI, Inc. on Wednesday said Sanofi-Aventis plans to end its agreement with the company, the latest in a slew of contract losses for the sales and marketing services ...
Co announces that it has signed an agreement with a top-five pharmaceutical company which is expected to generate approximately $23 million in revenue for PDI over its one year term. This new ...
Shares of PDI Inc. are climbing 68 cents, or 15 percent, to $5.15 after the pharmaceutical services company announced late Wednesday that it was awarded a two-year contract extension to provide sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback